RxDoctor Payments Data

James Seeley, MD

Family Medicine · Springfield, TNNPI 1568448736

Payments from drug & device makers

$2,523in general payments, 2019–2025

Across 187 payments — averaging $13.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$813
  • Lilly USA, LLC$229
  • AbbVie$226
  • AstraZeneca$222
  • GSK$221
  • Pfizer$121
  • plus $691 from 16 others

What the payments were for

  • Food & beverage$2,523100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,523 in reported general payments places this provider in the 70th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$39,933
Medicare patients
104
Services billed
403

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide77$86,147
EliquisApixaban67$57,727
FarxigaDapagliflozin Propanediol74$56,811
XareltoRivaroxaban54$49,863
Trelegy ElliptaFluticasone/Umeclidin/Vilanter61$49,277
Breo ElliptaFluticasone/Vilanterol71$39,025
JardianceEmpagliflozin44$37,341
RybelsusSemaglutide28$34,627
JanuviaSitagliptin Phosphate42$32,466
Tresiba Flextouch U-200Insulin Degludec15$16,053
JanumetSitagliptin Phos/Metformin Hcl11$12,665
MyrbetriqMirabegron15$11,574
KerendiaFinerenone16$10,527
Dexlansoprazole DrDexlansoprazole22$8,288
Aimovig AutoinjectorErenumab-Aooe11$7,906

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$101$120,774105 claims
GSKTrelegy Ellipta, Breo Ellipta$221$88,302132 claims
PfizerEliquis$121$57,72767 claims
AstraZenecaFarxiga$222$56,81174 claims
Johnson & JohnsonXarelto$13$49,86354 claims
MerckJanuvia, Janumet$16$45,13153 claims
Boehringer IngelheimJardiance$88$37,34144 claims
Lilly USA, LLCHumalog Mix 75-25$229$3,78419 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Springfield

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →